Bellerophon Therapeutics Inc. (BLPH)

0.60
0.01 2.30
NASDAQ : Health Technology
Prev Close 0.59
Open 0.61
Day Low/High 0.57 / 0.62
52 Wk Low/High 0.49 / 1.33
Volume 110.38K
Avg Volume 129.80K
Exchange NASDAQ
Shares Outstanding 68.91M
Market Cap 39.96M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bellerophon Announces Positive Top Line Phase 2 Data Of INOpulse® For Treatment Of Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

Bellerophon Announces Positive Top Line Phase 2 Data Of INOpulse® For Treatment Of Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease

Study Met its Primary and Secondary Endpoints Demonstrating Statistically Significant Improvements in Six-Minute Walking Distance, Hemodynamics and Blood Vessel Volume

Bellerophon Therapeutics Announces FDA Acceptance Of Modifications To INOpulse Pulmonary Arterial Hypertension Phase 3 Program

Bellerophon Therapeutics Announces FDA Acceptance Of Modifications To INOpulse Pulmonary Arterial Hypertension Phase 3 Program

Protocol Changes have Potential to Reduce Time to Market for INOpulse by Approximately Two Years and Will Result in Substantial Cost Savings for Company

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Bellerophon Therapeutics, Inc. And Advises Investors With Losses To Contact The Firm

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Bellerophon Therapeutics, Inc. And Advises Investors With Losses To Contact The Firm

Goldberg Law PC announces that it is investigating Bellerophon Therapeutics, Inc.

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.